The Medtronic Freestyle Aortic Root bioprosthesis is a technologically advanced stentless porcine valve. After an extensive clinical trial, the Freestyle bioprosthesis was commercially released internationally in January 1996, and received U.S. Food and Drug Administration (FDA) approval in November 1997.

Mosaic®, the third generation tissue valve from Medtronic, is the only third generation stented tissue valve available. The Mosaic valve builds upon three decades of tissue valve experience and is an excellent choice for patients who require aortic or mitral valve replacement with a tissue valve. The Medtronic Mosaic bioprosthesis is made of porcine (pig) tissue.

The Mitroflow Aortic Pericardial Heart Valve has been established as the heart valve of choice due to its outstanding haemodynamic performance and to more than 20 years of established clinical experience. Its unique design, together with a reliable and state-of-the-art manufacturing process offer a safe and versatile solution, which can be adapted to the most difficult anatomies.

THE ONLY BIOPROSTHESIS THAT MIMICS A NATIVE VALVE IN FORM AND FUNCTION. A unique aortic bioprothesis that mimics the native valve in form and function.

Mosaic®, the third generation tissue valve from Medtronic, is the only third generation stented tissue valve available. The Mosaic valve builds upon three decades of tissue valve experience and is an excellent choice for patients who require aortic or mitral valve replacement with a tissue valve.

Features

Supported by 15years of proven clinical validation, worldwide clinical studies demonstrate that the freedom from structural valve deterioration with Hancock® II aortic and mitral bioprostheses is substantially better than results reported for other valves.

The Hancock® II ULTRA™ Valve features a reduced sewing cuff and specifically designed to target implants in a small aortic root. With no less than 15years of proven clinical validation, worldwide clinical studies demonstrate that the freedom from structural valve deterioration with Hancock® II aortic and mitral bioprostheses is substantially better than results reported for other valves.

Carpentier-Edwards PERIMOUNT Plus Mitral Bioprosthesis with Tricentrix Holder and ThermaFix Advanced Tissue Process is fully integrated. The PERIMOUNT Theon mitral replacement systems design answers the specific challenges of mitral heart valve replacement, facilitate the implantation process, and maximize clinical outcomes for both surgeon and patient.

Mosaic®, the third generation tissue valve from Medtronic, is the only third generation stented tissue valve available. The Mosaic valve builds upon three decades of tissue valve experience and is an excellent choice for patients who require aortic or mitral valve replacement with a tissue valve. The Medtronic Mosaic bioprosthesis is made of porcine (pig) tissue.

With over 15years of proven clinical experience, worldwide clinical studies demonstrate that the freedom from structural valve deterioration with Hancock® II aortic and mitral bioprostheses is substantially better than results reported for other valves.

CINCH™ Advanced Implant System-Designed to ease implantability, a feature made possible by Medtronic’s flexible acetal homopolymer stent.

PericarbonTM Freedom Stentless valve is a unique pericardial stentless valve, result of Sorin Biomedica’s commitment intechnology applied to human life. Over two decades of clinical experience with bovine pericardium heart valves are proof of the success of Sorin’s unique method of combining innovative design with superior materials and high technology.

The Medtronic Freestyle Aortic Root bioprosthesis is a technologically advanced stentless porcine valve. After an extensive clinical trial, the Freestyle bioprosthesis was commercially released internationally in January 1996, and received U.S.

The PERIMOUNT Magna heart valve (bioprosthesis), with its true supra-annular design, offers optimal hemodynamics and flow characteristics for treatment of aortic heart valve disease. Enables up to 23% greater effective orifice area (EOA). Designed on the foundation of the PERIMOUNT tissue (pericardial) heart valve's unparalleled 20-year durability.

The SJM Biocor Stented Valve System—which includes aortic, mitral, and supra valves—provides the industry's lowest implant profile with 20 years of established clinical experience. The valve design of the SJM Biocor Stented Valve System provides easy positioning within the cardiac anatomy.

Features: